CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11 enrolled
Drug / intervention
Testing for SARS CoV2 RNAdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05607043
NCT05607043N/ACompleted
CompareCT.gov

Rutgers Pilot for Pragmatic Return to Effective Dental Infection Control Through Triage and Testing (PREDICT)- Patient LAB Test

Rutgers, The State University of New Jersey·interventional·Posted Nov 7, 2022·Updated Sep 22, 2023

In Brief

A clinical study evaluating Testing for SARS CoV2 RNA for SARS-CoV2 Infection. Completed, enrolled 11 participants across 1 site.

Detailed Summary

A pilot study was initiated to assess feasibility of testing asymptomatic dental patients presenting to the Oral Medicine Clinic at Rutgers School of Dental Medicine for SARS-CoV-2 viral RNA using an FDA approved RT-PCR test for SARS-CoV2- an RNA RT-PCR assay (Accurate Diagnostics)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSARS-CoV2 Infection
CountriesUnited States
CollaboratorsNational Institute of Dental and Craniofacial Research (NIDCR)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 7, 2022
Enrollment StartJan 31, 2021
Primary CompletionFeb 25, 2021
TodayJul 2, 2026
Enrollment to primary: 24 daysPosted 3.7 years ago

Interventions

Testing for SARS CoV2 RNAdevice

Device: Testing for SARS CoV2 RNA- lab-based RNA RT-PCR testing